Delayed BME 03:59:15 2024-05-21 am EDT 5-day change 1st Jan Change
10.2 EUR 0.00% Intraday chart for Prim, S.A. 0.00% -2.39%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 228M 248M Sales 2025 * - Capitalization 177M 192M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 0.74 x
Net cash position 2024 * 9.08M 9.87M Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
8.98 x
P/E ratio 2025 *
-
Employees 900
Yield 2024 *
5.56%
Yield 2025 *
-
Free-Float 47.28%
More Fundamentals * Assessed data
Dynamic Chart
Current month+0.49%
1 month+2.00%
6 months-2.86%
Current year-2.39%
More quotes
1 week
10.10
Extreme 10.1
10.25
1 month
9.96
Extreme 9.96
10.35
Current year
9.50
Extreme 9.5
10.75
1 year
9.50
Extreme 9.5
12.05
3 years
9.50
Extreme 9.5
15.75
5 years
8.00
Extreme 8
15.75
10 years
5.98
Extreme 5.98
15.75
More quotes
Managers TitleAgeSince
Chief Executive Officer - 20-10-31
Director of Finance/CFO - 17-06-30
Chairman - 19-09-29
Members of the board TitleAgeSince
Director/Board Member - 18-10-27
- -
Director/Board Member - 20-05-06
More insiders
Date Price Change Volume
24-05-21 10.2 0.00% 245
24-05-20 10.2 0.00% 450
24-05-17 10.2 +0.49% 1,384
24-05-16 10.15 -0.49% 1,298
24-05-15 10.2 0.00% 7,442

Delayed Quote BME, May 21, 2024 at 03:59 am EDT

More quotes
Prim SA is a Spain-based company principally engaged in the provision of hospital supplies. The Company’s products portfolio comprises implantable orthopedic products, silicone foot products, abduction splints, mastectomy lingerie, prosthetic components, as well as articulated electric beds and various types of accessories for geriatric centers. Through its subsidiary Inmobiliaria Catharsis SA, the Company is also active in the Real State sector. Prim SA is a parent of Grupo Prim, a group which comprises such a number of controlled entities as Enraf Nonius Iberica SA, Establecimientos Ortopedicos Prim SA, and Luga Suministros Medicos SL, among others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.2 EUR
Average target price
16.75 EUR
Spread / Average Target
+64.22%
Consensus

Annual profits - Rate of surprise

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW